|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase IV
|
|
|
|
Diagnostic, Treatment
|
|
|
|
Completed
|
|
|
|
18 to 63
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
3068A1-400 NCT00418236
|
|
|
|
|
|
|
|
Last Modified: 12/14/2007  First Published: 7/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Prevention
|
|
|
|
Closed
|
|
|
|
35 and over
|
|
|
|
NCI
|
|
|
|
NSABP-P-2 NCT00003906, NSABP-P-2
|
|
|
|
|
|
|
|
Last Modified: 5/26/2005  First Published: 8/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Prevention
|
|
|
|
Completed
|
|
|
|
23 to 47
|
|
|
|
NCI
|
|
|
|
NCI-98-C-0123 MB-402, NCT00019500
|
|
|
|
|
|
|
|
Last Modified: 10/2/2003  First Published: 2/1/2000 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Prevention, Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
MSKCC-99017 NCI-G99-1662, NCT00004247
|
|
|
|
|
|
|
|
Last Modified: 8/1/2000  First Published: 3/1/2000 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
NU-98G1 NCI-G00-1710, NCT00004915
|
|
|
|
|
|
|
|
Last Modified: 12/1/2002  First Published: 3/1/2002 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Supportive care
|
|
|
|
Closed
|
|
|
|
Any age
|
|
|
|
NCI
|
|
|
|
OHSU-6312 NCI-H02-0086, NCT00031811
|
|
|
|
|
|
|
|
Last Modified: 5/8/2007  First Published: 3/1/2002 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Prevention
|
|
|
|
Completed
|
|
|
|
30 to 45
|
|
|
|
Other
|
|
|
|
NCRI-IBIS-RAZOR EU-20053, UKCCCR-IBIS-RAZOR, ISRCTN17775670, NCT00031850
|
|
|
|